MaaT Has Pathway To Microbiome Market Mapped Out
Phase III Trial In Europe Progressing Well
Executive Summary
Freed from a lengthy FDA clinical hold, the French biotech is advancing on a variety of fronts, business development head Savita Bernal tells Scrip.